BioCryst Pharmaceuticals Inc (BCRX)
NASDAQ
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Cash from Operating Activities | -138M | -161.85M | -47.51M | -66.33M | -86.22M | -95.14M | -53.68M | -55.05M |
Cash from Investing Activities | -205.45M | -128.24M | -107.11M | -126.14M | -103.03M | -131.5M | 28.76M | 26.31M |
Cash from Financing Activities | 83.83M | 88.03M | 5.08M | 34.43M | 35.66M | 32.49M | -1.05M | -3.01M |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Cash from Operating Activities | -53.44M | -41.14M | -92.57M | -89.58M | -137.22M | -142.16M | -161.85M | -95.14M |
Cash from Investing Activities | 23.34M | -66.38M | 4.77M | 77.93M | -6.86M | 15.8M | -128.24M | -131.5M |
Cash from Financing Activities | 23.3M | 135.7M | 62.5M | 99.1M | 302.7M | 359.67M | 88.03M | 32.49M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.